Systematic SARS-CoV-2-testing for asymptomatic cancer patients treated at a public healthcare tertiary centre in Brazil
Short Communication
[키워드] acute respiratory syndrome
adherent
affected
age
anticancer
Asymptomatic
asymptomatic patient
Asymptomatic testing
base
Brazil
Cancer
cancer patient
carried
Characteristics
Chemotherapy
Cohort
Complication
consequence
coronavirus
coronavirus disease
COVID-19
demographic
demonstrated
determine
Eligible patients
enrolled
female
gastrointestinal tract
healthcare
higher risk
highest
hospital
hygiene
hypothesise
increased risk
independent
Infection
means
Measures
median
metastatic disease
Most patient
nasal
oropharyngeal swab
outcome
pandemic
Patient
patients
Patients with cancer
physical distancing
polymerase chain
positive
pre-symptomatic
Prevalence
prevalence of COVID-19
proportions
public health
receiving
Result
RNA
severe disease
solid cancer
solid tumour
tested
therapy
Transmissibility
treated
Treatment
were excluded
white
[DOI] 10.3332/ecancer.2021.1269 PMC 바로가기 [Article Type] Short Communication
[DOI] 10.3332/ecancer.2021.1269 PMC 바로가기 [Article Type] Short Communication